Invokana Diabetes Drug Lawsuit

Miskin Law offices are now accepting client retainers for Canadians related to Janssen’s diabetes drug Invokana for a Canadian class action.  We have already been retained by several people with very serious problems from this medication.  We expect a class action claim to be issued soon. Invokana was released on the market in the USA
Read More >>

STATUS OF CLASS ACTION SETTLEMENT FOR VIOXX

  THE VIOXX CLASS ACTION SETTLEMENT FOR CANADA IS BEING IMPLEMENTED. FILING CLAIMS OPENED APRIL 20, 2013 AND CLOSED AUGUST 19, 2013. CLAIMS ARE STILL BEING ASSESSED BY THE CLAIMS ADMINISTRATOR AS OF APRIL 2015.  THIS POST DETAILS HOW THE SETTLEMENT PROCESS PROCEEDED.  FOR UP TO DATE INFORMATION ON THE STATUS OF CLAIM NOW PLEASE
Read More >>

Celebrex Class Action Lawsuit Settlement Compared

    PLEASE BE AWARE THAT THE DEADLINE FOR SUBMITTING CELEBREX OR BEXTRA CLAIMS PASSED ON DECEMBER 20, 2012 Pfizer’s Cox 2 inhibitor drug Celebrex is similar to Merck’s Vioxx and Pfizer’s more powerful version Bextra.  Celebrex remains on the market and Bextra was banned soon after Vioxx in 2004.  While Merck’s equivalent drug Vioxx
Read More >>

Merck Vioxx Class Action Settlement Court Approval

THIS IS AN APRIL 20, 2013 UPDATE OF INFORMATION ABOUT COURT APPROVAL OF THE SETTLEMENT OF THE CANADIAN VIOXX CLASS ACTION NEGOTIATED WITH MERCK BY THE CANADIAN CLASS ACTION LAW FIRMS AND ANNOUNCED OVER A YEAR AGO IN JANUARY 2012. THE SETTLEMENT WAS CONDITIONAL ON COURT APPROVAL AFTER CONSIDERING THE FAIRNESS OF THE TERMS OF
Read More >>

  • Miskin Law Posts

    • GET YOUR FREE CASE EVALUATION